Nyu Langone Health — New York, New York

Nyu Langone Health is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Nyu Langone Health has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma.

Sponsors: Caribou Biosciences, Inc., BeOne Medicines.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nyu Langone Health?

Nyu Langone Health has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nyu Langone Health conducted?

Nyu Langone Health has 2 clinical trials on record, with 2 currently active. Their work covers Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma.

Is Nyu Langone Health accredited by Crixeo Health?

Nyu Langone Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nyu Langone Health?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.